Skip to content

Electroacupuncture and rTMS for Post-Stroke Motor Recovery

Efficacy and Safety of Electroacupuncture Combined With rTMS on Motor Function Recovery After Stroke: A Multi-center Randomized Controlled Clinical Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07113990
Enrollment
180
Registered
2025-08-11
Start date
2025-08-27
Completion date
2027-12-31
Last updated
2025-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Electroacupuncture; Repetitive Transcranial Magnetic Stimulation (rTMS); Stroke Rehabilitation; Motor Function ; Multicenter Randomized Controlled Trial

Brief summary

This study aims to evaluate the combined efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) and Electroacupuncture (EA) in improving motor function recovery post-stroke, compared to rTMS combined with sham EA. Participants will receive either active EA or sham EA alongside standard rTMS treatment. Outcomes will be assessed using standardized clinical scales and neuroimaging techniques to explore underlying neuroplasticity mechanisms.

Detailed description

Motor impairment is a major cause of disability following stroke, with central and peripheral neuromodulation strategies showing potential for functional recovery. Repetitive transcranial magnetic stimulation (rTMS) has been shown to promote neuroplasticity and enhance cortical excitability. Electroacupuncture (EA), by increasing somatosensory input, may further strengthen sensorimotor integration and cortical remodeling. However, limited clinical trials have systematically evaluated the synergistic effect of rTMS combined with EA. This multi-center randomized controlled clinical study aims to assess the efficacy of combining rTMS and EA in improving motor function post-stroke. Outcome measures include clinical scales (FMA, ARAT, FAC), kinematic parameters, electrophysiological indices (EEG, EMG, TMS), blood biomarkers, and resting-state fMRI. The study is designed to explore central-peripheral neuroplasticity mechanisms and provide evidence for integrated rehabilitation approaches.

Interventions

PROCEDUREActive EA

Participants will receive electroacupuncture once daily for 2 consecutive weeks (total 10 sessions). Disposable sterile needles will be inserted at standardized acupoints to achieve de qi, then connected to an electroacupuncture device for 30 minutes per session.

PROCEDURESham EA

Participants will receive sham electroacupuncture once daily for 2 consecutive weeks (total 10 sessions). Disposable blunt needles will be placed at the same acupoints without skin penetration or electrical stimulation, with the electroacupuncture device turned on but delivering no current, for 30 minutes per session.

DEVICEActive rTMS

Participants will receive high-frequency rTMS to the ipsilesional M1 area once daily for 2 consecutive weeks (total 10 sessions). Stimulation will be delivered with a MagPro R30 stimulator at 10 Hz, 1600 pulses per session, 4-second trains with 41-second inter-train intervals.

Sponsors

Jing Tao
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with stroke confirmed by neuroimaging (CT/MRI). * First-ever stroke, unilateral hemispheric lesion, related to motor dysfunction. * Age between 40 and 75 years. * Duration from stroke onset between 2 weeks and 6 months. * Brunnstrom stage II-IV. * Right-handed. * Able to understand instructions and voluntarily provide written informed consent.

Exclusion criteria

* History of epilepsy or familial epilepsy. * Motor dysfunction due to non-vascular causes (e.g., tumor, trauma). * Severe aphasia or cognitive impairment (MoCA \< 18). * Severe systemic complications (e.g., severe organ dysfunction, deep vein thrombosis). * Presence of metallic implants or contraindications for MRI. * Severe anxiety (HAMA \> 7) or depression (HAMD \> 8). * Severe spasticity (modified Ashworth ≥ 2). * Fear or intolerance of TMS or electroacupuncture. * Pregnancy, breastfeeding, or concurrent participation in other clinical trials affecting outcomes.

Design outcomes

Primary

MeasureTime frameDescription
Fugl-Meyer Assessment (FMA)Baseline, 2 weeks post-intervention, 1month follow-up, 3months follow-upThe Fugl-Meyer Assessment is used for rating motor function recovery after stroke. Scores range from 0 to 100, with higher scores indicating better motor performance.

Secondary

MeasureTime frameDescription
Arm Research Action Test (ARAT)Baseline, 2 weeks post-intervention, 1month follow-up, 3months follow-upThe Arm Research Action Test is used for assessing upper limb motor function across grasp, grip, pinch, and gross movement domains. Scores range from 0 to 57, with higher scores indicating better upper limb function.
Functional Ambulation Classification (FAC)Baseline, 2 weeks post-intervention, 1month follow-up, 3months follow-upThe Functional Ambulation Classification is used for evaluating the degree of ambulation independence. Scores range from 0 to 5, with higher scores indicating greater ambulation capability.
Modified Barthel Index (MBI)Baseline, 2 weeks post-intervention, 1month follow-up, 3months follow-upThe Modified Barthel Index is used for rating the level of independence in daily living activities. Scores range from 0 to 100, with higher scores indicating better functional independence.
Stroke-Specific Quality of Life Scale (SS-QOL)Baseline, 2 weeks post-intervention, 1month follow-up, 3months follow-upThe Stroke-Specific Quality of Life Scale is used for assessing health-related quality of life across 12 domains. Scores range from 49 to 245, with higher scores indicating better perceived quality of life.

Other

MeasureTime frameDescription
Blood BiomarkersBaseline, 2 weeks post-interventionCirculating neuroplasticity and inflammation biomarkers in venous blood samples.
Electrophysiological Assessments (EMG, EEG, TMS)Baseline, 2 weeks post-interventionElectromyography (EMG), electroencephalography (EEG) and transcranial magnetic stimulation (TMS) assessments. Note: This outcome is planned to be conducted at selected sites depending on equipment availability and final coordination. The specific evaluation sites are under discussion.
fMRIBaseline, 2 weeks post-interventionStructural and functional MRI acquired on a 3 T scanner. Note: This outcome will be assessed only at Fujian Provincial Hospital (Affiliated Hospital of Fuzhou University).
Kinematic Analysis of Upper Limb Motor TasksBaseline, 2 weeks post-intervention, 1month follow-up, 3months follow-upOptical motion capture of limb movement kinematics during functional tasks

Countries

China

Contacts

Primary ContactJing Tao, PhD
taojing01@fjtcm.edu.cn(+86)0591-22861227
Backup ContactQingping Su, MD
(+86)15280409492

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026